Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remco A Koster

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Clinical Chemistry and Laboratory Medicine|August 3, 2019
Performance of a web-based application measuring spot quality in dried blood spot samplingHerman Veenhof, Remco A Koster, Randy Brinkman, et al.
Bioanalysis|July 23, 2020
UHPLC-MS/MS method for iohexol determination in human EDTA and lithium-heparin plasma, human urine and in goat- and pig EDTA plasmaJasper Stevens, Mireille A Wessels, Jan Roggeveld, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 3, 2024
Everolimus decreases [U-<sup>13</sup>C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivoGerke Ariaans, Jiske F Tiersma, Bernardus Evers, et al.
Clinical Chemistry and Laboratory Medicine|April 3, 2019
Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patientsHerman Veenhof, Remco A Koster, Jan-Willem C Alffenaar, et al.
Research in Developmental Disabilities|May 3, 2016
Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysisJoanneke E L VanDerNagel, Marion Kiewik, Marike van Dijk, et al.
The Journal of Clinical Psychiatry|October 26, 2017
Dried Blood Spot Analysis for Therapeutic Drug Monitoring of ClozapineLisanne M Geers, Dan Cohen, Laura M Wehkamp, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|August 29, 2022
Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45]Johanna Kuhlin, Marieke G G Sturkenboom, Samiksha Ghimire, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|December 22, 2021
Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugsJohanna Kuhlin, Marieke G G Sturkenboom, Samiksha Ghimire, et al.
Therapeutic Drug Monitoring|July 4, 2019
Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug MonitoringSara Capiau, Herman Veenhof, Remco A Koster, et al.
Therapeutic Drug Monitoring|June 7, 2019
Quality Assessment of Dried Blood Spots from Patients With Tuberculosis from 4 CountriesMarlanka A Zuur, Herman Veenhof, Alena Aleksa, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Chemistry and Laboratory Medicine|August 3, 2019
Performance of a web-based application measuring spot quality in dried blood spot samplingHerman Veenhof, Remco A Koster, Randy Brinkman, et al.
Bioanalysis|July 23, 2020
UHPLC-MS/MS method for iohexol determination in human EDTA and lithium-heparin plasma, human urine and in goat- and pig EDTA plasmaJasper Stevens, Mireille A Wessels, Jan Roggeveld, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 3, 2024
Everolimus decreases [U-<sup>13</sup>C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivoGerke Ariaans, Jiske F Tiersma, Bernardus Evers, et al.
Clinical Chemistry and Laboratory Medicine|April 3, 2019
Clinical application of a dried blood spot assay for sirolimus and everolimus in transplant patientsHerman Veenhof, Remco A Koster, Jan-Willem C Alffenaar, et al.
Research in Developmental Disabilities|May 3, 2016
Substance use in individuals with mild to borderline intellectual disability: A comparison between self-report, collateral-report and biomarker analysisJoanneke E L VanDerNagel, Marion Kiewik, Marike van Dijk, et al.
The Journal of Clinical Psychiatry|October 26, 2017
Dried Blood Spot Analysis for Therapeutic Drug Monitoring of ClozapineLisanne M Geers, Dan Cohen, Laura M Wehkamp, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab|August 29, 2022
Corrigendum to "Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugs" [Clin. Mass Spectrom. 14(Part A) (2019) 34-45]Johanna Kuhlin, Marieke G G Sturkenboom, Samiksha Ghimire, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|December 22, 2021
Mass spectrometry for therapeutic drug monitoring of anti-tuberculosis drugsJohanna Kuhlin, Marieke G G Sturkenboom, Samiksha Ghimire, et al.
Therapeutic Drug Monitoring|July 4, 2019
Official International Association for Therapeutic Drug Monitoring and Clinical Toxicology Guideline: Development and Validation of Dried Blood Spot-Based Methods for Therapeutic Drug MonitoringSara Capiau, Herman Veenhof, Remco A Koster, et al.
Therapeutic Drug Monitoring|June 7, 2019
Quality Assessment of Dried Blood Spots from Patients With Tuberculosis from 4 CountriesMarlanka A Zuur, Herman Veenhof, Alena Aleksa, et al.
Pageof 3